| Mark A Farthing, DC | |
|
2006 Foulk Rd, Ste B, Wilmington, DE 19810-3644 | |
| (302) 529-8783 | |
| Not Available |
| Full Name | Mark A Farthing |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 18 Years |
| Location | 2006 Foulk Rd, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083639900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | F10000649 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation Associates Pa | 7416948526 | 17 |
News Archive
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
Bedfont, a breath monitoring equipment manufacturer, announced it developed a tool that can aid parents in testing their kids for cigarette and marijuana use.
Infants and toddlers in low-income, rural areas may be at higher risk for second- and third-hand smoke than previously reported, according to new Penn State-led research.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 9 days ago
| Provider Name | Rehabilitation Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679509160 PECOS PAC ID: 7416948526 Enrollment ID: O20040519000159 |
News Archive
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
Bedfont, a breath monitoring equipment manufacturer, announced it developed a tool that can aid parents in testing their kids for cigarette and marijuana use.
Infants and toddlers in low-income, rural areas may be at higher risk for second- and third-hand smoke than previously reported, according to new Penn State-led research.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark A Farthing, DC 2006 Foulk Road, Ste B, Wilmington, DE 19810 Ph: (302) 529-8783 | Mark A Farthing, DC 2006 Foulk Rd, Ste B, Wilmington, DE 19810-3644 Ph: (302) 529-8783 |
News Archive
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
Bedfont, a breath monitoring equipment manufacturer, announced it developed a tool that can aid parents in testing their kids for cigarette and marijuana use.
Infants and toddlers in low-income, rural areas may be at higher risk for second- and third-hand smoke than previously reported, according to new Penn State-led research.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 9 days ago
Shavneet Kler, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3411 Silverside Road., 106 Weldin Building, Wilmington, DE 19810 Phone: 302-650-4542 Fax: 302-371-9800 | |
Matthew Paul Weik, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1426 N Clayton St, Wilmington, DE 19806 Phone: 302-300-4242 Fax: 302-300-4241 | |
Joseph George Gaglioti, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1400 Philadelphia Pike, Suite A4, Wilmington, DE 19809 Phone: 302-778-9996 Fax: 302-296-0996 | |
Dr. Desiree Paramore, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 6 Sharpley Rd, Wilmington, DE 19803 Phone: 850-980-2206 | |
Dr. Nicole Jean Stoessel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2207 Concord Pike # 207, Wilmington, DE 19803 Phone: 302-256-8622 Fax: 302-340-7444 | |
Newlife Spinal Care Centers Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1305 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-6575 Fax: 302-994-2374 | |
Timothy John Ciolkosz, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3105 Limestone Rd, Suite303, Wilmington, DE 19808 Phone: 302-993-9113 Fax: 302-993-0313 |